Cargando…

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab

Detalles Bibliográficos
Autores principales: Zhu, Changhua, Fok, Jie Shen, Lin, Lihang, Su, Huichun, Maurer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880337/
https://www.ncbi.nlm.nih.gov/pubmed/36712834
http://dx.doi.org/10.1016/j.jdcr.2022.12.009
_version_ 1784878886472908800
author Zhu, Changhua
Fok, Jie Shen
Lin, Lihang
Su, Huichun
Maurer, Marcus
author_facet Zhu, Changhua
Fok, Jie Shen
Lin, Lihang
Su, Huichun
Maurer, Marcus
author_sort Zhu, Changhua
collection PubMed
description
format Online
Article
Text
id pubmed-9880337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98803372023-01-28 Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab Zhu, Changhua Fok, Jie Shen Lin, Lihang Su, Huichun Maurer, Marcus JAAD Case Rep Case Report Elsevier 2022-12-28 /pmc/articles/PMC9880337/ /pubmed/36712834 http://dx.doi.org/10.1016/j.jdcr.2022.12.009 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Zhu, Changhua
Fok, Jie Shen
Lin, Lihang
Su, Huichun
Maurer, Marcus
Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_full Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_fullStr Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_full_unstemmed Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_short Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
title_sort complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880337/
https://www.ncbi.nlm.nih.gov/pubmed/36712834
http://dx.doi.org/10.1016/j.jdcr.2022.12.009
work_keys_str_mv AT zhuchanghua completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT fokjieshen completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT linlihang completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT suhuichun completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab
AT maurermarcus completeresponsetodupilumabinapatientwithchronicspontaneousurticariawhodidnottolerateomalizumab